Brian Rose, PA
Physician Assistant · Raeford, NCNPI 1578079356
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $53,926 of the $84,497 with a category attached, or 63.8%. Bayer accounts for 62.9% of it on its own, with 27 other manufacturers making up the rest. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 485 payments — averaging $174.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$53K
- Lexicon Pharmaceuticals, Inc.$13K
- Johnson & Johnson$5K
- Scpharmaceuticals Inc.$4K
- Amgen$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- plus $7K from 22 others
What the payments were for
- Consulting fees$6,3728%
- Speaking & faculty fees$53,92664%
- Travel & lodging$10,47612%
- Food & beverage$13,70916%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 109 | $53,184 |
| Lexicon Pharmaceuticals, Inc. | 41 | $12,701 |
| Johnson & Johnson | 45 | $5,030 |
| Scpharmaceuticals Inc. | 7 | $4,080 |
| Amgen | 65 | $1,251 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 53 | $1,190 |
| Esperion Therapeutics, Inc. | 5 | $1,141 |
| AstraZeneca | 19 | $958 |
| Actelion Pharmaceuticals US, Inc. | 14 | $845 |
| Novo Nordisk | 13 | $603 |
| United Therapeutics Corporation | 18 | $589 |
| Boehringer Ingelheim | 11 | $479 |
| Novartis | 28 | $417 |
| E.r. Squibb & Sons, L.L.C. | 19 | $340 |
| Merck | 17 | $330 |
| Medtronic | 5 | $299 |
| Boston Scientific | 4 | $222 |
| Abiomed | 1 | $132 |
| Abbott | 1 | $126 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $120 |
| Anika Therapeutics, Inc. | 1 | $104 |
| Acumed LLC | 1 | $103 |
| Organogenesis Inc. | 2 | $51 |
| Bridgebio Pharma, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $21 |
| Pfizer | 1 | $15 |
| Elutia, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$84,497 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 415 | $377,226 |
| XareltoRivaroxaban | 354 | $293,138 |
| KerendiaFinerenone | 197 | $169,514 |
| Repatha SureclickEvolocumab | 140 | $162,144 |
| EntrestoSacubitril/Valsartan | 116 | $120,979 |
| EliquisApixaban | 91 | $104,348 |
| FuroscixFurosemide | 16 | $89,117 |
| FarxigaDapagliflozin Propanediol | 98 | $84,187 |
| OzempicSemaglutide | 45 | $44,137 |
| BrilintaTicagrelor | 52 | $28,331 |
| VerquvoVericiguat | 24 | $19,701 |
| InpefaSotagliflozin | 21 | $12,004 |
| LokelmaSodium Zirconium Cyclosilicate | 11 | $11,028 |
| Praluent PenAlirocumab | 16 | $9,595 |
| CorlanorIvabradine Hcl | 12 | $8,160 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $479 | $377,226415 claims |
| Johnson & JohnsonXarelto | $5,030 | $293,138354 claims |
| BayerKerendia | $53,184 | $169,514197 claims |
| AstraZenecaFarxiga, Brilinta, Lokelma | $958 | $123,546161 claims |
| NovartisEntresto | $417 | $120,979116 claims |
| PfizerEliquis | $15 | $104,34891 claims |
| Scpharmaceuticals Inc.Furoscix | $4,080 | $89,11716 claims |
| Novo NordiskOzempic | $603 | $44,13745 claims |
| MerckVerquvo | $330 | $19,70124 claims |
| Lexicon Pharmaceuticals, Inc.Inpefa | $12,701 | $12,00421 claims |
| AmgenCorlanor | $1,251 | $8,16012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Raeford
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.